Research news
The trial will test whether drug treatment with a commonly prescribed dementia drug can improve balance and walking and help to prevent falls in people with Parkinson's.
New research shows that scrapping prescription charges for Parkinson's and inflammatory bowel disease could save the NHS money.
We are pleased to announce that a Parkinson's research project has been awarded the inaugural BenevolentAI Award. The project will use an artificial intelligence platform’s capabilities to reason, deduce and suggest entirely new treatments for Parkinson’s.
An international team has developed a cutting-edge technique, enabling human brain tissue to be studied in 3D.
New international research suggests that too much calcium inside brain cells may trigger a chain reaction that leads to Parkinson's.
We're partnering with US company Neurolixis to accelerate the development of a drug that could prevent dyskinesia, a debilitating side effect of Parkinson's medication.
A study, featured in the Daily Mail, suggests a link between certain types of flu and risk of Parkinson's.
New figures from Parkinson's UK show that more than 12,000 Scots are now living with Parkinson's, and numbers are continuing to rise.
Researchers in Japan have discovered that people with Parkinson's may have lower levels of caffeine in their blood after drinking tea and coffee.
Research supported by Parkinson's UK has identified a medicine used to treat tapeworm infections which could lead to new treatments for people with Parkinson's.